Role of autophagy in breast cancer and breast cancer stem cells (Review)
- Authors:
- Yanyan Han
- Shujun Fan
- Tao Qin
- Jinfeng Yang
- Yan Sun
- Ying Lu
- Jun Mao
- Lianhong Li
-
Affiliations: Department of Pathology, Dalian Medical University, Liaoning 116044, P.R. China - Published online on: February 8, 2018 https://doi.org/10.3892/ijo.2018.4270
- Pages: 1057-1070
This article is mentioned in:
Abstract
Dandawate PR, Subramaniam D, Jensen RA and Anant S: Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. Semin Cancer Biol. 40–41:192–208. 2016. View Article : Google Scholar : PubMed/NCBI | |
Vessoni AT, Filippi-Chiela EC, Menck CF and Lenz G: Autophagy and genomic integrity. Cell Death Differ. 20:1444–1454. 2013. View Article : Google Scholar : PubMed/NCBI | |
Mizushima N, Levine B, Cuervo AM and Klionsky DJ: Autophagy fights disease through cellular self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI | |
Mowers EE, Sharifi MN and Macleod KF: Autophagy in cancer metastasis. Oncogene. 36:1619–1630. 2017. View Article : Google Scholar : | |
Ruocco N, Costantini S and Costantini M: Blue-print autophagy: Potential for cancer treatment. Mar Drugs. 14:142016. View Article : Google Scholar | |
Wang C, Hu Q and Shen HM: Pharmacological inhibitors of autophagy as novel cancer therapeutic agents. Pharmacol Res. 105:164–175. 2016. View Article : Google Scholar : PubMed/NCBI | |
Lee JS, Kim YJ, Kim CL and Lee GM: Differential induction of autophagy in caspase-3/7 down-regulating and Bcl-2 overexpressing recombinant CHO cells subjected to sodium butyrate treatment. J Biotechnol. 161:34–41. 2012. View Article : Google Scholar : PubMed/NCBI | |
Knutson BA: Insights into the domain and repeat architecture of target of rapamycin. J Struct Biol. 170:354–363. 2010. View Article : Google Scholar : PubMed/NCBI | |
Sauer E, Imseng S, Maier T and Hall MN: Conserved sequence motifs and the structure of the mTOR kinase domain. Biochem Soc Trans. 41:889–895. 2013. View Article : Google Scholar : PubMed/NCBI | |
Yang H, Rudge DG, Koos JD, Vaidialingam B, Yang HJ and Pavletich NP: mTOR kinase structure, mechanism and regulation. Nature. 497:217–223. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kim DH, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H, Tempst P and Sabatini DM: GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell. 11:895–904. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kaizuka T, Hara T, Oshiro N, Kikkawa U, Yonezawa K, Takehana K, Iemura S, Natsume T and Mizushima N: Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. J Biol Chem. 285:20109–20116. 2010. View Article : Google Scholar : PubMed/NCBI | |
Takai H, Wang RC, Takai KK, Yang H and de Lange T: Tel2 regulates the stability of PI3K-related protein kinases. Cell. 131:1248–1259. 2007. View Article : Google Scholar : PubMed/NCBI | |
Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, Gray NS and Sabatini DM: DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell. 137:873–886. 2009. View Article : Google Scholar : PubMed/NCBI | |
Wullschleger S, Loewith R and Hall MN: TOR signaling in growth and metabolism. Cell. 124:471–484. 2006. View Article : Google Scholar : PubMed/NCBI | |
Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, et al: FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6:458–471. 2007. View Article : Google Scholar : PubMed/NCBI | |
Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH and Goldberg AL: FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 6:472–483. 2007. View Article : Google Scholar : PubMed/NCBI | |
Moscat J and Diaz-Meco MT: p62 at the crossroads of autophagy, apoptosis, and cancer. Cell. 137:1001–1004. 2009. View Article : Google Scholar : PubMed/NCBI | |
Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S and Sabatini DM: Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell. 141:290–303. 2010. View Article : Google Scholar : PubMed/NCBI | |
Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L and Sabatini DM: The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science. 320:1496–1501. 2008. View Article : Google Scholar : PubMed/NCBI | |
Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y and Sabatini DM: mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science. 334:678–683. 2011. View Article : Google Scholar : PubMed/NCBI | |
Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, et al: A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31:1095–1108. 2012. View Article : Google Scholar : PubMed/NCBI | |
Copetti T, Bertoli C, Dalla E, Demarchi F and Schneider C: p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol. 29:2594–2608. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lu C, Wang W, Jia Y, Liu X, Tong Z and Li B: Inhibition of AMPK/autophagy potentiates parthenolide-induced apoptosis in human breast cancer cells. J Cell Biochem. 115:1458–1466. 2014. View Article : Google Scholar : PubMed/NCBI | |
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI | |
Abdal Dayem A, Choi HY, Yang GM, Kim K, Saha SK and Cho SG: The anti-cancer effect of polyphenols against breast cancer and cancer stem cells: Molecular mechanisms. Nutrients. 8:581–618. 2016. View Article : Google Scholar : | |
Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F and Paredes J: Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression distribution within intrinsic molecular subtype. J Clin Pathol. 64:937–946. 2011. View Article : Google Scholar : PubMed/NCBI | |
Idowu MO, Kmieciak M, Dumur C, Burton RS, Grimes MM, Powers CN and Manjili MH: CD44(+)/CD24(−/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Hum Pathol. 43:364–373. 2012. View Article : Google Scholar | |
Ahmed MA, Aleskandarany MA, Rakha EA, Moustafa RZ, Benhasouna A, Nolan C, Green AR, Ilyas M and Ellis IO: A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer. Breast Cancer Res Treat. 133:979–995. 2012. View Article : Google Scholar | |
Fonseca NA, Cruz AF, Moura V, Simões S and Moreira JN: The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors. Crit Rev Oncol Hematol. 113:111–121. 2017. View Article : Google Scholar : PubMed/NCBI | |
Ingham PW and McMahon AP: Hedgehog signaling in animal development: Paradigms and principles. Genes Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI | |
McMahon AP, Ingham PW and Tabin CJ: Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol. 53:1–114. 2003. View Article : Google Scholar : PubMed/NCBI | |
Murone M, Rosenthal A and de Sauvage FJ: Sonic hedgehog signaling by the patched-smoothened receptor complex. Curr Biol. 9:76–84. 1999. View Article : Google Scholar : PubMed/NCBI | |
Bray SJ: Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol. 7:678–689. 2006. View Article : Google Scholar : PubMed/NCBI | |
Ishii H, Iwatsuki M, Ieta K, Ohta D, Haraguchi N, Mimori K and Mori M: Cancer stem cells and chemoradiation resistance. Cancer Sci. 99:1871–1877. 2008. View Article : Google Scholar : PubMed/NCBI | |
Wang M, Zhang J, Huang Y, Ji S, Shao G, Feng S, Chen D, Zhao K, Wang Z and Wu A: Cancer-associated fibroblasts autophagy enhances progression of triple-negative breast cancer cells. Med Sci Monit. 23:3904–3912. 2017. View Article : Google Scholar : PubMed/NCBI | |
Sun R, Shen S, Zhang YJ, Xu CF, Cao ZT, Wen LP and Wang J: Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells. Biomaterials. 103:44–55. 2016. View Article : Google Scholar : PubMed/NCBI | |
Liang DH, Choi DS, Ensor JE, Kaipparettu BA, Bass BL and Chang JC: The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair. Cancer Lett. 376:249–258. 2016. View Article : Google Scholar : PubMed/NCBI | |
Bincoletto C, Bechara A, Pereira GJS, Santos CP, Antunes F, Peixoto da-Silva J, Muler M, Gigli RD, Monteforte PT, Hirata H, et al: Interplay between apoptosis and autophagy, a challenging puzzle: New perspectives on antitumor chemotherapies. Chem Biol Interact. 206:279–288. 2013. View Article : Google Scholar : PubMed/NCBI | |
Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, Brunner T and Simon HU: Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol. 8:1124–1132. 2006. View Article : Google Scholar : PubMed/NCBI | |
DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N and Coussens LM: CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 16:91–102. 2009. View Article : Google Scholar : PubMed/NCBI | |
Mukhopadhyay S, Panda PK, Sinha N, Das DN and Bhutia SK: Autophagy and apoptosis: Where do they meet? Apoptosis. 19:555–566. 2014. View Article : Google Scholar : PubMed/NCBI | |
Yao D, Wang P, Zhang J, Fu L, Ouyang L and Wang J: Deconvoluting the relationships between autophagy and metastasis for potential cancer therapy. Apoptosis. 21:683–698. 2016. View Article : Google Scholar : PubMed/NCBI | |
Han Q, Deng Y, Chen S, Chen R, Yang M, Zhang Z, Sun X, Wang W, He Y, Wang F, et al: Downregulation of ATG5-dependent macroautophagy by chaperone-mediated autophagy promotes breast cancer cell metastasis. Sci Rep. 7:47592017. View Article : Google Scholar : PubMed/NCBI | |
Kongara S, Kravchuk O, Teplova I, Lozy F, Schulte J, Moore D, Barnard N, Neumann CA, White E and Karantza V: Autophagy regulates keratin 8 homeostasis in mammary epithelial cells and in breast tumors. Mol Cancer Res. 8:873–884. 2010. View Article : Google Scholar : PubMed/NCBI | |
Kuraishy A, Karin M and Grivennikov SI: Tumor promotion via injury- and death-induced inflammation. Immunity. 35:467–477. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kung CP, Budina A, Balaburski G, Bergenstock MK and Murphy M: Autophagy in tumor suppression and cancer therapy. Crit Rev Eukaryot Gene Expr. 21:71–100. 2011. View Article : Google Scholar : PubMed/NCBI | |
White E and DiPaola RS: The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI | |
Choi KS: Autophagy and cancer. Exp Mol Med. 44:109–120. 2012. View Article : Google Scholar : PubMed/NCBI | |
Denton D, Nicolson S and Kumar S: Cell death by autophagy: Facts and apparent artefacts. Cell Death Differ. 19:87–95. 2012. View Article : Google Scholar : | |
Maycotte P, Jones KL, Goodall ML, Thorburn J and Thorburn A: Autophagy supports breast cancer stem cell maintenance by regulating IL6 secretion. Mol Cancer Res. 13:651–658. 2015. View Article : Google Scholar : PubMed/NCBI | |
Wolf J, Dewi DL, Fredebohm J, Müller-Decker K, Flechtenmacher C, Hoheisel JD and Boettcher M: A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype. Breast Cancer Res. 15:R1092013. View Article : Google Scholar : PubMed/NCBI | |
Gong C, Bauvy C, Tonelli G, Yue W, Deloménie C, Nicolas V, Zhu Y, Domergue V, Marin-Esteban V, Tharinger H, et al: Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene. 32:2261–2272. 1–11. 2013. View Article : Google Scholar : | |
Zhao Y, Huang Q, Yang J, Lou M, Wang A, Dong J, Qin Z and Zhang T: Autophagy impairment inhibits differentiation of glioma stem/progenitor cells. Brain Res. 1313:250–258. 2010. View Article : Google Scholar | |
Singh BN, Kumar D, Shankar S and Srivastava RK: Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol. 84:1154–1163. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kumar D, Shankar S and Srivastava RK: Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: Molecular mechanisms. Mol Cancer. 12:1712013. View Article : Google Scholar : PubMed/NCBI | |
Wei MF, Chen MW, Chen KC, Lou PJ, Lin SY, Hung SC, Hsiao M, Yao CJ and Shieh MJ: Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells. Autophagy. 10:1179–1192. 2014. View Article : Google Scholar : PubMed/NCBI | |
Yue W, Hamaï A, Tonelli G, Bauvy C, Nicolas V, Tharinger H, Codogno P and Mehrpour M: Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy. 9:714–729. 2013. View Article : Google Scholar : PubMed/NCBI | |
Chiang GG and Abraham RT: Targeting the mTOR signaling network in cancer. Trends Mol Med. 13:433–442. 2007. View Article : Google Scholar : PubMed/NCBI | |
Xu K, Liu P and Wei W: mTOR signaling in tumorigenesis. Biochim Biophys Acta. 1846:638–654. 2014.PubMed/NCBI | |
Mateo F, Arenas EJ, Aguilar H, Serra-Musach J, de Garibay GR, Boni J, Maicas M, Du S, Iorio F, Herranz-Ors C, et al: Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition. Oncogene. 36:2737–2749. 2017. View Article : Google Scholar : | |
Zhang L, Fu L, Zhang S, Zhang J, Zhao Y, Zheng Y, He G, Yang S, Ouyang L and Liu B: Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem Sci (Camb). 8:2687–2701. 2017. View Article : Google Scholar | |
Jang JE, Eom JI, Jeung HK, Cheong JW, Lee JY, Kim JS and Min YH: Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells. Autophagy. 13:761–762. 2017. View Article : Google Scholar : PubMed/NCBI | |
Zhou Y, Rucker EB III and Zhou BP: Autophagy regulation in the development and treatment of breast cancer. Acta Biochim Biophys Sin (Shanghai). 48:60–74. 2016. | |
Yeo SK, Wen J, Chen S and Guan JL: Autophagy differentially regulates distinct breast cancer stem-like cells in murine models via EGFR/Stat3 and Tgfβ/Smad signaling. Cancer Res. 76:3397–3410. 2016. View Article : Google Scholar : PubMed/NCBI | |
Nagy P, Kovács L, Sándor GO and Juhász G: Stem-cell-specific endocytic degradation defects lead to intestinal dysplasia in Drosophila. Dis Model Mech. 9:501–512. 2016. View Article : Google Scholar : PubMed/NCBI | |
Liu K, Zhao Q, Liu P, Cao J, Gong J, Wang C, Wang W, Li X, Sun H, Zhang C, et al: ATG3-dependent autophagy mediates mitochondrial homeostasis in pluripotency acquirement and maintenance. Autophagy. 12:2000–2008. 2016. View Article : Google Scholar : PubMed/NCBI | |
Zhang L, Li J, Ouyang L, Liu B and Cheng Y: Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy. Cancer Lett. 373:19–26. 2016. View Article : Google Scholar : PubMed/NCBI | |
Antonelli M, Strappazzon F, Arisi I, Brandi R, D'Onofrio M, Sambucci M, Manic G, Vitale I, Barilà D and Stagni V: ATM kinase sustains breast cancer stem-like cells by promoting ATG4C expression and autophagy. Oncotarget. 8:21692–21709. 2017. View Article : Google Scholar : PubMed/NCBI | |
Liu H, He Z, von Rütte T, Yousefi S, Hunger RE and Simon HU: Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma. Sci Transl Med. 5:202ra1232013. View Article : Google Scholar : PubMed/NCBI | |
Debnath J: The multifaceted roles of autophagy in tumors-implications for breast cancer. J Mammary Gland Biol Neoplasia. 16:173–187. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chaterjee M and van Golen KL: Breast cancer stem cells survive periods of farnesyl-transferase inhibitor-induced dormancy by undergoing autophagy. Bone Marrow Res. 2011:3629382011. View Article : Google Scholar : PubMed/NCBI | |
Memni H, Macherki Y, Klayech Z, Ben-Haj-Ayed A, Farhat K, Remadi Y, Gabbouj S, Mahfoudh W, Bouzid N, Bouaouina N, et al: E-cadherin genetic variants predict survival outcome in breast cancer patients. J Transl Med. 14:3202016. View Article : Google Scholar : PubMed/NCBI | |
Zhuang W, Li B, Long L, Chen L, Huang Q and Liang Z: Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer. 129:2720–2731. 2011. View Article : Google Scholar : PubMed/NCBI | |
Qin Z, Xue J, He Y, Ma H, Jin G, Chen J, Hu Z, Liu X and Shen H: Potentially functional polymorphisms in ATG10 are associated with risk of breast cancer in a Chinese population. Gene. 527:491–495. 2013. View Article : Google Scholar : PubMed/NCBI | |
Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS and Pochampally RR: Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis. 32:964–972. 2011. View Article : Google Scholar : PubMed/NCBI | |
Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Corominas-Faja B, Urruticoechea A, Martin-Castillo B and Menendez JA: Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment. Oncotarget. 3:1600–1614. 2012. View Article : Google Scholar | |
Chang SJ, Ou-Yang F, Tu HP, Lin CH, Huang SH, Kostoro J, Hou MF, Chai CY and Kwan AL: Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24−/low) indicate poor prognosis in triple-negative breast cancer. Hum Pathol. 48:48–55. 2016. View Article : Google Scholar : PubMed/NCBI | |
Carpenter RL, Sirkisoon S, Zhu D, Rimkus T, Harrison A, Anderson A, Paw I, Qasem S, Xing F, Liu Y, et al: Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth. Oncotarget. 8:73947–73963. 2017. View Article : Google Scholar : PubMed/NCBI | |
Petherick KJ, Williams AC, Lane JD, Ordóñez-Morán P, Huelsken J, Collard TJ, Smartt HJ, Batson J, Malik K, Paraskeva C, et al: Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J. 32:1903–1916. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Han C, Lu L, Magliato S and Wu T: Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells. Hepatology. 58:995–1010. 2013. View Article : Google Scholar : PubMed/NCBI | |
Espina V and Liotta LA: What is the malignant nature of human ductal carcinoma in situ? Nat Rev Cancer. 11:68–75. 2011. View Article : Google Scholar | |
Yang H, Zheng Y, Zhang Y, Cao Z and Jiang Y: Mesenchymal stem cells derived from multiple myeloma patients protect against chemotherapy through autophagy-dependent activation of NF-κB signaling. Leuk Res. 60:82–88. 2017. View Article : Google Scholar : PubMed/NCBI | |
Huang S, Wang D, Zhang S, Huang X, Wang D, Ijaz M and Shi Y: Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer. Cancer Chemother Pharmacol. 80:685–696. 2017. View Article : Google Scholar : PubMed/NCBI | |
Sharma N, Thomas S, Golden EB, Hofman FM, Chen TC, Petasis NA, Schönthal AH and Louie SG: Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett. 326:143–154. 2012. View Article : Google Scholar : PubMed/NCBI | |
Ma YW, Liu YZ and Pan JX: Verteporfin induces apoptosis and eliminates cancer stem-like cells in uveal melanoma in the absence of light activation. Am J Cancer Res. 6:2816–2830. 2016. | |
Shi TT, Yu XX, Yan LJ and Xiao HT: Research progress of hydroxychloroquine and autophagy inhibitors on cancer. Cancer Chemother Pharmacol. 79:287–294. 2017. View Article : Google Scholar | |
Solomon VR, Almnayan D and Lee H: Design, synthesis and characterization of novel quinacrine analogs that preferentially kill cancer over non-cancer cells through the down-regulation of Bcl-2 and up-regulation of Bax and Bad. Eur J Med Chem. 137:156–166. 2017. View Article : Google Scholar : PubMed/NCBI | |
Siddharth S, Nayak D, Nayak A, Das S and Kundu CN: ABT-888 and quinacrine induced apoptosis in metastatic breast cancer stem cells by inhibiting base excision repair via adenomatous polyposis coli. DNA Repair (Amst). 45:44–55. 2016. View Article : Google Scholar | |
Mishra P, Dauphinee AN, Ward C, Sarkar S, Gunawardena AHLAN and Manjithaya R: Discovery of pan autophagy inhibitors through a high-throughput screen highlights macro-autophagy as an evolutionarily conserved process across 3 eukaryotic kingdoms. Autophagy. 13:1556–1572. 2017. View Article : Google Scholar : PubMed/NCBI | |
Liang S, Chen Z, Jiang G, Zhou Y, Liu Q, Su Q, Wei W, Du J and Wang H: Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Cancer Lett. 386:12–23. 2017. View Article : Google Scholar | |
Torrente E, Parodi C, Ercolani L, De Mei C, Ferrari A, Scarpelli R and Grimaldi B: Synthesis and in vitro anticancer activity of the first cass of dual inhibitors of REV-ERBβ and autophagy. J Med Chem. 58:5900–5915. 2015. View Article : Google Scholar : PubMed/NCBI | |
Zhou X, Yue GG, Chan AM, Tsui SK, Fung KP, Sun H, Pu J and Lau CB: Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer. Biochem Pharmacol. 142:58–70. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wong VKW, Zeng W, Chen J, Yao XJ, Leung ELH, Wang QQ, Chiu P, Ko BCB and Law BYK: Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-α inhibition and mTOR-dependent mechanisms. Front Pharmacol. 8:3512017. View Article : Google Scholar | |
Han H, Li J, Feng X, Zhou H, Guo S and Zhou W: Autophagy-related genes are induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid via the activation of cathepsin B in human breast cancer cells. Oncotarget. 8:53352–53365. 2017.PubMed/NCBI | |
Chen X, Yu X, Chen J, Yang Z, Shao Z, Zhang Z, Guo X and Feng Y: Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1-T2 disease and one to three positive lymph nodes after mastectomy. Oncologist. 18:141–147. 2013. View Article : Google Scholar : PubMed/NCBI | |
Chen X, Yu X, Chen J, Zhang Z, Tuan J, Shao Z, Guo X and Feng Y: Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: Patterns of failure and prognostic factors. Cancer. 119:2366–2374. 2013. View Article : Google Scholar : PubMed/NCBI | |
Liu EY, Xu N, O'Prey J, Lao LY, Joshi S, Long JS, O'Prey M, Croft DR, Beaumatin F, Baudot AD, et al: Loss of autophagy causes a synthetic lethal deficiency in DNA repair. Proc Natl Acad Sci USA. 112:773–778. 2015. View Article : Google Scholar : PubMed/NCBI | |
Zhou ZR, Yang ZZ, Wang SJ, Zhang L, Luo JR, Feng Y, Yu XL, Chen XX and Guo XM: The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy. Acta Pharmacol Sin. 38:513–523. 2017. View Article : Google Scholar : PubMed/NCBI | |
Davison Z, de Blacquière GE, Westley BR and May FEB: Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: Implications for therapy. Neoplasia. 13:504–515. 2011. View Article : Google Scholar : PubMed/NCBI | |
Wu W, Ma J, Shao N, Shi Y, Liu R, Li W, Lin Y and Wang S: Co-targeting IGF-1R and autophagy enhances the effects of cell growth suppression and apoptosis induced by the IGF-1R inhibitor NVP-AEW541 in triple-negative breast cancer cells. PLoS One. 12:e01692292017. View Article : Google Scholar : PubMed/NCBI | |
Maxfield KE, Macion J, Vankayalapati H and Whitehurst AW: SIK2 restricts autophagic flux to support triple-negative breast cancer survival. Mol Cell Biol. 36:3048–3057. 2016. View Article : Google Scholar : PubMed/NCBI | |
Gao J, Fan M, Peng S, Zhang M, Xiang G, Li X, Guo W, Sun Y, Wu X, Wu X, et al: Small-molecule RL71-triggered excessive autophagic cell death as a potential therapeutic strategy in triple-negative breast cancer. Cell Death Dis. 8:e30492017. View Article : Google Scholar : PubMed/NCBI | |
Zhang P, Liu X, Li H, Chen Z, Yao X, Jin J and Ma X: TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway. Sci Rep. 7:31582017. View Article : Google Scholar | |
Liu Z, Shi A, Song D, Han B, Zhang Z, Ma L, Liu D and Fan Z: Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. Am J Cancer Res. 7:574–583. 2017.PubMed/NCBI | |
Poillet-Perez L, Jacquet M, Hervouet E, Gauthier T, Fraichard A, Borg C, Pallandre JR, Gonzalez BJ, Ramdani Y, Boyer-Guittaut M, et al: GABARAPL1 tumor suppressive function is independent of its conjugation to autophagosomes in MCF-7 breast cancer cells. Oncotarget. 8:55998–56020. 2017. View Article : Google Scholar : PubMed/NCBI | |
Rodríguez CE, Reidel SI, Bal de Kier Joffé ED, Jasnis MA and Fiszman GL: Autophagy protects from trastuzumab-induced cytotoxicity in HER2 overexpressing breast tumor spheroids. PLoS One. 10:e01379202015. View Article : Google Scholar : PubMed/NCBI | |
Zambrano J, Yeh ES and Zambrano J: Autophagy and apoptotic crosstalk: Mechanism of therapeutic resistance in HER2-positive breast cncer. Breast Cancer (Auckl). 10:13–23. 2016. | |
Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Corominas-Faja B, Cuyàs E, López-Bonet E, Martin-Castillo B, Joven J and Menendez JA: The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer. Sci Rep. 3:24692013. View Article : Google Scholar : PubMed/NCBI | |
Garbar C, Mascaux C, Giustiniani J, Merrouche Y and Bensussan A: Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231. Sci Rep. 7:72012017. View Article : Google Scholar : PubMed/NCBI | |
Maycotte P, Gearheart CM, Barnard R, Aryal S, Mulcahy Levy JM, Fosmire SP, Hansen RJ, Morgan MJ, Porter CC, Gustafson DL, et al: STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious. Cancer Res. 74:2579–2590. 2014. View Article : Google Scholar : PubMed/NCBI | |
Wang S, Wang K, Wang H, Han J and Sun H: Autophagy is essential for flavopiridol-induced cytotoxicity against MCF-7 breast cancer cells. Mol Med Rep. 16:9715–9720. 2017. View Article : Google Scholar : PubMed/NCBI | |
Chang CT, Korivi M, Huang HC, Thiyagarajan V, Lin KY, Huang PJ, Liu JY, Hseu YC and Yang HL: Inhibition of ROS production, autophagy or apoptosis signaling reversed the anticancer properties of Antrodia salmonea in triple-negative breast cancer (MDA-MB-231) cells. Food Chem Toxicol. 103:1–17. 2017. View Article : Google Scholar : PubMed/NCBI | |
Zheng N, Liu L, Liu WW, Li F, Hayashi T, Tashiro SI, Onodera S and Ikejima T: Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro. Acta Pharmacol Sin. 38:277–289. 2017. View Article : Google Scholar : | |
Liu ZY, He KW, Song XG, Wang XZ, Zhuo PY, Wang XW, Ma QH, Huo ZJ and Yu ZY: Effect of autophagy inhibitor combined with EGFR inhibitor on triple-negative breast cancer MDA-MB-468 and MDA-MB-231 cells. Zhonghua Zhong Liu Za Zhi. 38:417–424. 2016.In Chinese. PubMed/NCBI | |
Tran AT, Ramalinga M, Kedir H, Clarke R and Kumar D: Autophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cells. Eur J Nutr. 54:265–272. 2015. View Article : Google Scholar | |
Liu Z, He K, Ma Q, Yu Q, Liu C, Ndege I, Wang X and Yu Z: Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer. PLoS One. 12:e01776942017. View Article : Google Scholar : PubMed/NCBI | |
Wang H, Wang W, Xu Y, Yang Y, Chen X, Quan H and Lou L: Aberrant intracellular metabolism of T-DM1 confers T-DM1 resistance in human epidermal growth factor receptor 2-positive gastric cancer cells. Cancer Sci. 108:1458–1468. 2017. View Article : Google Scholar : PubMed/NCBI | |
Gong C, Hu C, Gu F, Xia Q, Yao C, Zhang L, Qiang L, Gao S and Gao Y: Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment. J Control Release. 266:272–286. 2017. View Article : Google Scholar : PubMed/NCBI | |
Shen P, Chen M, He M, Chen L, Song Y, Xiao P, Wan X, Dai F, Pan T and Wang Q: Inhibition of ERα/ERK/P62 cascades induces 'autophagic switch' in the estrogen receptor-positive breast cancer cells exposed to gemcitabine. Oncotarget. 7:48501–48516. 2016. View Article : Google Scholar : PubMed/NCBI | |
Li HC, Xia ZH, Chen YF, Yang F, Feng W, Cai H, Mei Y, Jiang YM, Xu K and Feng DX: Cantharidin inhibits the growth of triple-negative breast cancer cells by suppressing autophagy and inducing apoptosis in vitro and in vivo. Cell Physiol Biochem. 43:1829–1840. 2017. View Article : Google Scholar : PubMed/NCBI | |
Gu Y, Chen T, Li G, Xu C, Xu Z, Zhang J, He K, Zheng L, Guan Z, Su X, et al: Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer. Oncotarget. 8:52156–52177. 2016. |